News
Bildnachweis: neoplas med, WITENO, neoplas med. neoplas med GmbH from Greifswald, Germany, is considered a pioneer in medical ...
Bildnachweis: AVEGA Capital Management. Observers of the political landscape in Germany saw a glimpse of light last year: ...
Bildnachweis: PwC. For corporations seeking to maintain a competitive edge and corporate venture capital (CVC) arms striving ...
Bildnachweis: Life Science Factory, Avocet Bio, VC Magazin, Pixabay. The Life Science Factory offers founders from research ...
Bildnachweis: ITM Isotope Technologies Munich SE, VC Magazin, Pixabay. As the global demand for targeted cancer therapies ...
Bildnachweis: BIO Deutschland, BioM, EY, BCG, Biomed X, VC Magazin, Pixabay. In principle, Germany has excellent prerequisites, but does not currently play a leading role internationally in the life ...
Germany’s start-ups are off to a great start in 2025. As per the KfW Venture Capital Dashboard, high-potential German ventures raked in EUR 1.6 billion in funding in Q1 2025 – a 14% jump from the ...
There are many uncertainties in the world, but this much is certain: the demand for innovative life sciences solutions will continue to grow, from research to therapy development. Despite regulatory ...
When using AI in clinical trials, stakeholders point to the challenges associated with the use of AI in clinical trials, amongst others the need to ensure transparency by tracking the AI logic which ...
Xue Huang has worked for well-known start-up unicorns such as Uber and Mobike in China, as well as with start-up founders across various industries for over a decade before moving to Australia. She ...
Gitex Global is the world’s largest tech and start-up event and gathers more than 5,000 companies and more than 100,000 visitors from 170 countries.. As a hub between Europe, Asia and Africa, the ...
Bildnachweis: VC Magazin. Start-ups, Wachstumsunternehmen, Investoren und Innovatoren aus ganz Deutschland trafen am 4. und 5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results